We provide you with 20 years of free, institutional-grade data for ANIP stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ANIP. Explore the full financial landscape of ANIP stock.
Reported Date | CIK | Ticker | Type | |
---|---|---|---|---|
2025-08-08 | 1023024 | ANIP | 10-Q | Url |
2025-05-09 | 1023024 | ANIP | 10-Q | Url |
2025-02-28 | 1023024 | ANIP | 10-K | Url |
2024-11-08 | 1023024 | ANIP | 10-Q | Url |
2024-08-06 | 1023024 | ANIP | 10-Q | Url |
2024-05-10 | 1023024 | ANIP | 10-Q | Url |
2024-02-29 | 1023024 | ANIP | 10-K | Url |
2023-11-08 | 1023024 | ANIP | 10-Q | Url |
2023-08-09 | 1023024 | ANIP | 10-Q | Url |
2023-05-08 | 1023024 | ANIP | 10-Q | Url |
2023-03-09 | 1023024 | ANIP | 10-K | Url |
2022-11-09 | 1023024 | ANIP | 10-Q | Url |
2022-08-08 | 1023024 | ANIP | 10-Q | Url |
2022-05-10 | 1023024 | ANIP | 10-Q | Url |
2022-03-15 | 1023024 | ANIP | 10-K | Url |
2021-11-01 | 1023024 | ANIP | 10-Q | Url |
2021-08-06 | 1023024 | ANIP | 10-Q | Url |
2021-05-07 | 1023024 | ANIP | 10-Q | Url |
2021-03-11 | 1023024 | ANIP | 10-K | Url |
2020-11-05 | 1023024 | ANIP | 10-Q | Url |
2020-08-06 | 1023024 | ANIP | 10-Q | Url |
2020-05-07 | 1023024 | ANIP | 10-Q | Url |
2020-02-27 | 1023024 | ANIP | 10-K | Url |
2019-11-06 | 1023024 | ANIP | 10-Q | Url |
2019-08-07 | 1023024 | ANIP | 10-Q | Url |
2019-05-09 | 1023024 | ANIP | 10-Q | Url |
2019-02-27 | 1023024 | ANIP | 10-K | Url |
2018-11-06 | 1023024 | ANIP | 10-Q | Url |
2018-08-07 | 1023024 | ANIP | 10-Q | Url |
2018-05-08 | 1023024 | ANIP | 10-Q | Url |
2018-02-27 | 1023024 | ANIP | 10-K | Url |
2017-11-02 | 1023024 | ANIP | 10-Q | Url |
2017-08-03 | 1023024 | ANIP | 10-Q | Url |
2017-05-04 | 1023024 | ANIP | 10-Q | Url |
2017-03-02 | 1023024 | ANIP | 10-K | Url |
2016-11-03 | 1023024 | ANIP | 10-Q | Url |
2016-08-04 | 1023024 | ANIP | 10-Q | Url |
2016-05-05 | 1023024 | ANIP | 10-Q | Url |
2016-02-23 | 1023024 | ANIP | 10-K | Url |
2015-11-03 | 1023024 | ANIP | 10-Q | Url |
2015-08-04 | 1023024 | ANIP | 10-Q | Url |
2015-05-05 | 1023024 | ANIP | 10-Q | Url |
2015-02-23 | 1023024 | ANIP | 10-K | Url |
2014-11-10 | 1023024 | ANIP | 10-Q | Url |
2014-08-07 | 1023024 | ANIP | 10-Q | Url |
2014-05-12 | 1023024 | ANIP | 10-Q | Url |
2014-02-28 | 1023024 | ANIP | 10-K | Url |
2013-11-07 | 1023024 | ANIP | 10-Q | Url |
2013-08-09 | 1023024 | ANIP | 10-Q | Url |
2013-05-10 | 1023024 | ANIP | 10-Q | Url |
2013-02-28 | 1023024 | ANIP | 10-K | Url |
2012-11-08 | 1023024 | ANIP | 10-Q | Url |
2012-08-01 | 1023024 | ANIP | 10-Q | Url |
2012-05-08 | 1023024 | ANIP | 10-Q | Url |
2012-03-13 | 1023024 | ANIP | 10-K | Url |
2011-11-09 | 1023024 | ANIP | 10-Q | Url |
2011-08-05 | 1023024 | ANIP | 10-Q | Url |
2011-05-10 | 1023024 | ANIP | 10-Q | Url |
2011-03-16 | 1023024 | ANIP | 10-K | Url |
2010-11-12 | 1023024 | ANIP | 10-Q | Url |
2010-08-12 | 1023024 | ANIP | 10-Q | Url |
2010-05-14 | 1023024 | ANIP | 10-Q | Url |
2010-03-30 | 1023024 | ANIP | 10-K | Url |
2009-11-09 | 1023024 | ANIP | 10-Q | Url |
2009-08-07 | 1023024 | ANIP | 10-Q | Url |
2009-05-11 | 1023024 | ANIP | 10-Q | Url |
2009-03-16 | 1023024 | ANIP | 10-K | Url |
2008-11-10 | 1023024 | ANIP | 10-Q | Url |
2008-08-11 | 1023024 | ANIP | 10-Q | Url |
2008-05-09 | 1023024 | ANIP | 10-Q | Url |
2008-03-17 | 1023024 | ANIP | 10-K | Url |
2007-11-13 | 1023024 | ANIP | 10-Q | Url |
2007-08-14 | 1023024 | ANIP | 10-Q | Url |
2007-05-01 | 1023024 | ANIP | 10-Q | Url |
2007-03-27 | 1023024 | ANIP | 10-K | Url |
2006-11-14 | 1023024 | ANIP | 10-Q | Url |
2006-08-14 | 1023024 | ANIP | 10-Q | Url |
2006-05-12 | 1023024 | ANIP | 10-Q | Url |
2006-03-31 | 1023024 | ANIP | 10-K | Url |
2005-11-14 | 1023024 | ANIP | 10-Q | Url |
2005-08-12 | 1023024 | ANIP | 10-Q | Url |
2000-11-13 | 1023024 | ANIP | 10-Q | Url |
ANI Pharmaceuticals, Inc(NASDAQ:ANIP)

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, and other formulations. The co...
Website: http://www.anipharmaceuticals.com
Founded: 2001
Full Time Employees: 338
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report about ANIP stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.